BamSEC and AlphaSense Join Forces
Learn More

Charles River Laboratories International Inc.

NYSE: CRL    
Share price (11/22/24): $195.77    
Market cap (11/22/24): $10.0 billion
Search in Documents
Key Exhibits
External Links

Plans of Reorganization, Merger, Acquisition or Similar Filter

EX-2.1
from 8-K 72 pages Agreement and Plan of Merger by and Among Charles River Laboratories International, Inc., Memphis Merger Sub, Inc., Cognate Bioservices, Inc. and the Sellers’ Representative Named Herein Dated as of February 17, 2021
12/34/56
EX-2.1
from 8-K 79 pages Share Sale and Purchase Agreement Between (1)axa Lbo Fund V Supplementary Fpci
12/34/56
EX-2.2
from 8-K 14 pages Axa Lbo Fund V Supplementary Fpci Jean Francois Le Bigot Roy Forster Patrick Spies Blue Jazz Sas Blue Tango Sas Ctl International Sas Charles River Nederland B.V. Exclusivity Agreement February 12, 2019 Contents
12/34/56
EX-2.1
from 8-K 10 pages Plan of reorganization, merger, acquisition or similar
12/34/56
EX-2.2
from 8-K 23 pages Project Forest Commitment Letter
12/34/56
EX-2.1
from 10-K 72 pages Agreement and Plan of Merger by and Among Charles River Laboratories International, Inc., Pretzel Acquisition Corporation Wrh, Inc. and American Capital Equity III, LP, Solely in Its Capacity as the Stockholders’ Representative Dated as of January 6, 2016
12/34/56
EX-2.2
from 8-K ~5 pages Dated 1 April 2014 Project Penguin Amendment Agreement to the Sale & Purchase Agreement Between Charles River Laboratories Holdings Limited Charles River Nederland B.V. Galapagos N.V. and Galapagos B.V. Contents
12/34/56
EX-2.1
from 8-K >50 pages Dated 13 March 2014 Project Penguin Sale & Purchase Agreement Between Charles River Laboratories Holdings Limited Charles River Nederland B.V. Galapagos N.V. and Galapagos B.V. Contents
12/34/56
EX-2.1
from 8-K 10 pages Termination Agreement
12/34/56
EX-2.1
from SC 13D ~5 pages Joint Filing Agreement
12/34/56
EX-2.3
from 8-K 23 pages Voting Agreement
12/34/56
EX-2.3
from DEFA14A 23 pages Voting Agreement
12/34/56
EX-2.2
from DEFA14A 23 pages Execution Version J.P. Morgan Securities Inc. Banc of America Securities LLC Jpmorgan Chase Bank, N.A. Bank of America, N.A. 270 Park Avenue One Bryant Park New York, New York 10017 New York, New York 10036 April 26, 2010 $1,250,000,000 Senior Secured Credit Facilities Commitment Letter
12/34/56
EX-2.2
from 8-K 23 pages Execution Version J.P. Morgan Securities Inc. Banc of America Securities LLC Jpmorgan Chase Bank, N.A. Bank of America, N.A. 270 Park Avenue One Bryant Park New York, New York 10017 New York, New York 10036 April 26, 2010 $1,250,000,000 Senior Secured Credit Facilities Commitment Letter
12/34/56
EX-2.1
from 8-K 89 pages Agreement and Plan of Arrangement Dated as of April 26, 2010 Between Wuxi Pharmatech (Cayman) Inc. and Charles River Laboratories International, Inc
12/34/56
EX-2.1
from DEFA14A 89 pages Agreement and Plan of Arrangement Dated as of April 26, 2010 Between Wuxi Pharmatech (Cayman) Inc. and Charles River Laboratories International, Inc
12/34/56
EX-2.1
from 8-K ~50 pages Agreement and Plan of Merger Dated as of June 30, 2004 Among Charles River Laboratories International, Inc., Inveresk Research Group, Inc., Indigo Merger I Corp., and Indigo Merger II Corp
12/34/56
EX-2.1
from 10-Q >50 pages Plan of reorganization, merger, acquisition or similar
12/34/56
EX-2.5
from S-3 ~50 pages Plan of reorganization, merger, acquisition or similar
12/34/56
EX-2.4
from S-3 ~50 pages Plan of reorganization, merger, acquisition or similar
12/34/56